Can oxysterols have some interest in the treatment of tumors?
Beck
J P
JP
Université Louis Pasteur, Laboratoire de Recherches en Immunologie, Strasbourg, France.
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D000972:Antineoplastic Agents, Phytogenic / Q000627:therapeutic use; D002462:Cell Membrane / Q000187:drug effects; D002784:Cholesterol / Q000096:biosynthesis; D004354:Drug Screening Assays, Antitumor; D004365:Drugs, Chinese Herbal / Q000627:therapeutic use; D006801:Humans; D006888:Hydroxycholesterols / Q000494:pharmacology / Q000627:therapeutic use; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D007810:Lanosterol / Q000031:analogs & derivatives / Q000494:pharmacology / Q000627:therapeutic use; D008560:Membrane Fluidity / Q000187:drug effects; D051379:Mice; D009369:Neoplasms / Q000188:drug therapy; D009374:Neoplasms, Experimental / Q000188:drug therapy*; D013261:Sterols / Q000494:pharmacology / Q000627:therapeutic use*; D014407:Tumor Cells, Cultured / Q000187:drug effects
D000970:Antineoplastic Agents; D000972:Antineoplastic Agents, Phytogenic; D004365:Drugs, Chinese Herbal; D006888:Hydroxycholesterols; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D013261:Sterols; D007810:Lanosterol; C015316:lanostenol; D002784:Cholesterol